Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
QuintilesIMS
Queensland Health
Chubb
Covington
Harvard Business School
Merck
Express Scripts

Generated: April 21, 2018

DrugPatentWatch Database Preview

BROMOCRIPTINE MESYLATE Drug Profile

« Back to Dashboard

When do Bromocriptine Mesylate patents expire, and when can generic versions of Bromocriptine Mesylate launch?

Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Paddock Llc, and Sandoz Inc. and is included in six NDAs.

The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
Drug patent expirations by year for BROMOCRIPTINE MESYLATE
Pharmacology for BROMOCRIPTINE MESYLATE
Ingredient-typeErgolines
Drug ClassErgot Derivative
Medical Subject Heading (MeSH) Categories for BROMOCRIPTINE MESYLATE
Synonyms for BROMOCRIPTINE MESYLATE
.alpha.-Ergocryptine, methanesulfonate
(+)-Bromocriptine methanesulfonate
(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0;{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),2,9,12,14-penta
(4R,7R)-10-BROMO-N-[(1S,2S,4R,7S)-2-HYDROXY-7-(2-METHYLPROPYL)-5,8-DIOXO-4-(PROPAN-2-YL)-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,9,12(16),13-
(4R,7R)-10-BROMO-N-[(1S,2S,4R,7S)-2-HYDROXY-7-(2-METHYLPROPYL)-5,8-DIOXO-4-(PROPAN-2-YL)-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0(2),?]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2,9,12,14-PENT
(5 inverted exclamation mark |A)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Methanesulfonate
(5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman methanesulfonate
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt)
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate
(5xi,5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman methanesulfonate (salt)
(5xi,5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate (salt)
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
(6AR,9R)-5-bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate
(6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quin
08Y
13177-EP2272832A1
13177-EP2275420A1
13177-EP2277876A1
13177-EP2280008A2
13177-EP2287165A2
13177-EP2287166A2
13177-EP2292614A1
13177-EP2292620A2
13177-EP2295412A1
13177-EP2295413A1
13177-EP2295439A1
13177-EP2298731A1
13177-EP2298738A1
13177-EP2298779A1
13177-EP2311808A1
13177-EP2311818A1
13177-EP2311829A1
13177-EP2311837A1
13177-EP2316470A2
13177-EP2316834A1
2-Bromine-alpha-ergocryptine methanesulfonate
2-Bromo |A-Ergocryptine Mesylate
2-Bromo alpha-Ergocryptine Mesylate
2-Bromo-.alpha.-ergocryptine monomethanesulfonate
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate
2-Bromo-a-ergocryptine methanesulfonate salt
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergocryptine mesylate
2-Bromo-alpha-ergocryptine methanesulfonate
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-Bromo-alpha-ergokryptine-mesilate
2-Bromo-alpha-ergokryptine-mesilate [German]
2-bromoergocriptine
2-Bromoergocryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergocryptine monomethanesulfonate (salt)
2-Bromoergokryptine
22260-51-1
22260-51-1 (mesylate (salt))
25614-03-3
25614-03-3 (Parent)
3A64E3G5ZO
88085-EP2298415A1
88085-EP2298742A1
88085-EP2305648A1
93201-EP2272825A2
93201-EP2305633A1
AC-13601
AC1L1KXP
AC1L1KXS
AC1Q2716
AK397268
AKOS015896276
AKOS015961273
alpha-Ergocryptine, 2-bromo-, methanesulfonate
Alti-Bromocriptine
AN-17214
Apo-Bromocriptine
B 2134
B6298
Bagren
BC206491
BDBM81993
BIDD:GT0464
Biomol-NT_000005
BPBio1_001131
BRD-K14496212-001-01-1
Bromergocryptine
Bromergon
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
bromocriptine
Bromocriptine (mesylate)
Bromocriptine (USAN/INN)
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
Bromocriptine [USAN:INN:BAN]
Bromocriptine mesilate
Bromocriptine mesilate (JP17)
Bromocriptine mesylate (USP)
Bromocriptine mesylate [USAN:USP]
Bromocriptine mesylate [USAN]
Bromocriptine methanesulfonate
Bromocriptine+ (GTP-)
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromocryptine mesylate
Bromocryptine methanesulfonate
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
C32H40BrN5O5.CH4O3S
CAS-22260-51-1
CAS-25614-03-3
CB 154
CB 154 methanesulfonate (salt)
CB-154
CB-154 mesylate
CCG-204266
CCG-220121
CCG-221475
CCRIS 3244
CHEBI:3181
CHEBI:3182
CHEMBL1200503
CHEMBL493
CS-6048
Cycloset
D00780
D03165
D06YFA
DB01200
DSSTox_CID_197
DSSTox_CID_2687
DSSTox_GSID_20197
DSSTox_GSID_22687
DSSTox_RID_75426
DSSTox_RID_76692
DTXSID1022687
DTXSID6020197
EINECS 244-881-1
EINECS 247-128-5
Ergocryptine, 2-bromo-
Ergocryptine, 2-bromo- (8CI)
Ergocryptine, 2-bromo-(8CI)
ergolactin
Ergoset
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-,(5'-alpha)-
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
EU-0100171
FFP983J3OD
GTPL35
HMS1568I04
HMS3260D03
HY-12705A
I06-2158
J-016067
Lopac0_000171
LP00171
LS-64540
LS-7234
MolPort-006-123-738
N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide
NCGC00024584-03
NCGC00024584-04
NCGC00024584-05
NCGC00257268-01
NCGC00260856-01
NCI60_001365
NOJMTMIRQRDZMT-GSPXQYRGSA-N
NSC-169774
NSC169774
oline-9-carboxamide methanesulfonate
OZVBMTJYIDMWIL-AYFBDAFISA-N
Parlodel
Parlodel (TN)
Parlodel Snaptabs
PDSP2_001500
PL001219
PL011661
Pravidel
Prestwick_771
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SCHEMBL25297
SCHEMBL40559
SPBio_002101
SR-01000075356
SR-01000075356-1
Tox21_110907
Tox21_303597
Tox21_500171
UNII-3A64E3G5ZO
UNII-FFP983J3OD
ZINC53683151

US Patents and Regulatory Information for BROMOCRIPTINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lek Pharm BROMOCRIPTINE MESYLATE bromocriptine mesylate CAPSULE;ORAL 075100-001 Dec 10, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan BROMOCRIPTINE MESYLATE bromocriptine mesylate TABLET;ORAL 076962-001 Sep 24, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan BROMOCRIPTINE MESYLATE bromocriptine mesylate CAPSULE;ORAL 077226-001 Apr 4, 2005 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc BROMOCRIPTINE MESYLATE bromocriptine mesylate CAPSULE;ORAL 078899-001 Jul 30, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Moodys
Accenture
Merck
Chinese Patent Office
AstraZeneca
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.